Ken Sagou

500 total citations
16 papers, 257 citations indexed

About

Ken Sagou is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ken Sagou has authored 16 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ken Sagou's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Ken Sagou is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Ken Sagou collaborates with scholars based in Japan, United States and Austria. Ken Sagou's co-authors include Takaki Miyata, Mikhail Drobizhev, Takeharu Nagai, Wen-Hong Li, Lin Liu, Yoshiyuki Arai, Yongxin Zhao, Aleksander Rebane, Thomas E. Hughes and Yu-Fen Chang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS Pathogens.

In The Last Decade

Ken Sagou

15 papers receiving 255 citations

Peers

Countries citing papers authored by Ken Sagou

Since Specialization

Citations

This map shows the geographic impact of Ken Sagou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Sagou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Sagou more than expected).

Fields of papers citing papers by Ken Sagou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Sagou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Sagou. The network helps show where Ken Sagou may publish in the future.

Co-authorship network of co-authors of Ken Sagou

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Sagou. A scholar is included among the top collaborators of Ken Sagou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Sagou. Ken Sagou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway 2024 ·Nature Communications ·(unknown), Seitaro Terakura, (unknown), Yusuke Okuno, Yoshitaka Sato, Ken Sagou, (unknown), (unknown), (unknown), Peter Steinberger, Judith Leitner, Ryo Hanajiri, Makoto Murata, Hitoshi Kiyoi	7
2	Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation 2024 ·PLoS Pathogens ·Ken Sagou, Yoshitaka Sato, Yusuke Okuno, Takahiro Watanabe, Tomoki Inagaki, Yashiro Motooka, Shinya Toyokuni, Takayuki Murata, Hitoshi Kiyoi, Hiroshi Kimura	3
3	Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection 2022 ·Cell Communication and Signaling ·Yoshitaka Sato, (unknown), Yusuke Okuno, (unknown), Ken Sagou, (unknown), Takeshi Suzuki, Tomoki Inagaki, (unknown), Takahiro Watanabe, Masahiro Fujimuro, Takayuki Murata, Hiroshi Kimura	12
4	Permanent Impairment-Free, Relapse-Free Survival: A Novel Composite Endpoint to Evaluate Long-Term Success in Allogeneic Transplantation 2020 ·Biology of Blood and Marrow Transplantation ·(unknown), Kazutaka Ozeki, (unknown), Ken Sagou, Nobuaki Fukushima, Akio Kohno	1
5	Intrapatient variability in concentration/dose ratio of tacrolimus predicts transplant-associated thrombotic microangiopathy 2020 ·International Journal of Hematology ·Ken Sagou, Nobuaki Fukushima, (unknown), (unknown), Kazutaka Ozeki, Akio Kohno	1
6	Two‐photon microscopic observation of cell‐production dynamics in the developing mammalian neocortex in utero 2020 ·Development Growth & Differentiation ·(unknown), Tomoyasu Shinoda, Yuki Hattori, (unknown), (unknown), Yoshihiro Tanaka, Ken Sagou, Kanako Saito, (unknown), Tomomi Kotani, Akihito SANO, Toshihiko Fujimori, Takaki Miyata	3
7	Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy 2020 ·International Journal of Hematology ·Ken Sagou, Nobuaki Fukushima, (unknown), (unknown), Kazutaka Ozeki, Akio Kohno	4
8	Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms 2020 ·SHILAP Revista de lepidopterología ·Ken Sagou, Makoto Ito, (unknown), (unknown), (unknown), Nobuaki Fukushima, Kazutaka Ozeki, Ryuichi Fukuyama, Akio Kohno	3
9	Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation 2019 ·International Journal of Hematology ·(unknown), Kazutaka Ozeki, (unknown), Ken Sagou, Nobuaki Fukushima, Akio Kohno	10
10	Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use 2019 ·International Journal of Hematology ·Ken Sagou, (unknown), (unknown), Nobuaki Fukushima, Kazutaka Ozeki, Akio Kohno	0
11	Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation 2019 ·International Journal of Hematology ·(unknown), Kazutaka Ozeki, (unknown), Ken Sagou, Nobuaki Fukushima, Akio Kohno	6
12	Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Ken Sagou, Kazutaka Ozeki, (unknown), (unknown), Nobuaki Fukushima, Akio Kohno	16
13	Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities 2018 ·Biology of Blood and Marrow Transplantation ·(unknown), (unknown), Ken Sagou, Nobuaki Fukushima, Kazutaka Ozeki, Akio Kohno	2
14	Acute Megakaryoblastic Leukemia Developing as Donor Cell Leukemia after Umbilical Cord Blood Transplantation 2017 ·Internal Medicine ·(unknown), (unknown), Ken Sagou, (unknown), Nobuaki Fukushima, Kazutaka Ozeki, Akio Kohno	3
15	Neurogenin2‐d4Venus and Gadd45g‐d4Venus transgenic mice: Visualizing mitotic and migratory behaviors of cells committed to the neuronal lineage in the developing mammalian brain 2014 ·Development Growth & Differentiation ·(unknown), Ken Sagou, Hiroshi Kiyonari, (unknown), Mayumi Okamoto, Tomoyasu Shinoda, Ayano Kawaguchi, Takaki Miyata	15
16	Improved Orange and Red Ca²⁺ Indicators and Photophysical Considerations for Optogenetic Applications 2013 ·ACS Chemical Neuroscience ·Jiahui Wu, Lin Liu, Tomoki Matsuda, Yongxin Zhao, Aleksander Rebane, Mikhail Drobizhev, Yu-Fen Chang, (unknown), Yoshiyuki Arai, (unknown), Thomas E. Hughes, Ken Sagou, Takaki Miyata, Takeharu Nagai, Wen-Hong Li, Robert E. Campbell	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact